subject area of

• "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance  Academic Article
• 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors  Academic Article
• 24 hours in the life of HIV-1 in a T cell line  Academic Article
• 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies  Academic Article
• 3D molecular models of whole HIV-1 virions generated with cellPACK  Academic Article
• 4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms  Academic Article
• A "flip-flop" rotation stage for routine dual-axis electron cryotomography  Academic Article
• A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1  Academic Article
• A candidate live inactivatable attenuated vaccine for aids  Academic Article
• A chimeric hiv-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (gm-csf) domain induces enhanced antibody and t cell responses  Academic Article
• A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease  Academic Article
• A comparative immunogenicity study of hiv-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120  Academic Article
• A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies  Academic Article
• A conserved hiv gp120 glycoprotein structure involved in chemokine receptor binding  Academic Article
• A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase  Academic Article
• A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120  Academic Article
• A dynamic model of HIV integrase inhibition and drug resistance  Academic Article
• A gene-specific role for the Ssu72 RNAPII CTD phosphatase in HIV-1 Tat transactivation  Academic Article
• A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly  Academic Article
• A general purpose RNA-cleaving DNA enzyme  Academic Article
• A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control  Academic Article
• A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2g12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120  Academic Article
• A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs  Academic Article
• A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1  Academic Article
• A large array of human monoclonal-antibodies to type-1 human-immunodeficiency-virus from combinatorial libraries of asymptomatic seropositive individuals  Academic Article
• A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals  Academic Article
• A live-virus ''suicide'' vaccine for human immunodeficiency virus  Academic Article
• A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41  Academic Article
• A metallopeptide assembly of the HIV-1 gp41 coiled coil is an ideal receptor in fluorescence detection of ligand binding  Academic Article
• A method for identification of hiv gp140 binding memory b cells in human blood  Academic Article
• A model for neutralization of viruses based on antibody coating of the virion surface  Academic Article
• A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene  Academic Article
• A new perspective on V3 phenotype prediction  Academic Article
• A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies  Academic Article
• A nonfucosylated variant of the anti-hiv-1 monoclonal antibody b12 has enhanced fc gamma riiia-mediated antiviral activity in vitro but does not improve protection against mucosal shiv challenge in macaques  Academic Article
• A nonself sugar mimic of the hiv glycan shield shows enhanced antigenicity  Academic Article
• A novel human antibody against human immunodeficiency virus type 1 gp120 is v1, v2, and v3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin g1 b12  Academic Article
• A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C  Academic Article
• A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield  Academic Article
• A short segment of the hiv-1 gp120 v1/v2 region is a major determinant of resistance to v1/v2 neutralizing antibodies  Academic Article
• A specific protein disorder catalyzer of HIV-1 Nef  Academic Article
• A structure-based approach to a synthetic vaccine for hiv-1  Academic Article
• A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5  Academic Article
• A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein  Academic Article
• A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry  Academic Article
• A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection  Academic Article
• A vaccine for hiv type 1: The antibody perspective  Academic Article
• A whole-genome association study of major determinants for host control of HIV-1  Academic Article
• AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges  Academic Article
• Absence of specific mucosal antibody responses in hiv-exposed uninfected sex workers from the gambia  Academic Article
• Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1  Academic Article
• Accessory mutations maintain stability in drug-resistant HIV-1 protease  Academic Article
• Active site binding modes of curcumin in HIV-1 protease and integrase  Academic Article
• Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication  Academic Article
• Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid)  Academic Article
• Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins  Academic Article
• Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy  Academic Article
• Affinity maturation of a potent family of HIV antibodies is primarily focused on accommodating or avoiding glycans  Academic Article
• Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex  Academic Article
• Alteration of methamphetamine-induced stereotypic behaviour in transgenic mice expressing hiv-1 envelope protein gp120  Academic Article
• Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system  Academic Article
• Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy  Academic Article
• An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells  Academic Article
• An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription  Academic Article
• An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation  Academic Article
• An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10  Academic Article
• An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor  Academic Article
• An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription  Academic Article
• An aptamer that neutralizes r5 strains of hiv-1 binds to core residues of gp120 in the ccr5 binding site  Academic Article
• An aptamer that neutralizes r5 strains of human immunodeficiency virus type 1 blocks gp120-ccr5 interaction  Academic Article
• An hla-c-restricted cd8+ cytotoxic lymphocyte-t clone recognizes a highly conserved epitope on human-immunodeficiency-virus type-1 gag  Academic Article
• An α-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction  Academic Article
• Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries  Academic Article
• Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell  Academic Article
• Analysis of RNA processing reactions using cell free systems: 3' end cleavage of pre-mRNA substrates in vitro  Academic Article
• Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors  Academic Article
• Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals  Academic Article
• Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis b surface antigen particles  Academic Article
• Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the hiv type 1 envelope glycoprotein 120  Academic Article
• Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein  Academic Article
• Analysis of the neutralization breadth of the anti-v3 antibody f425-b4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis  Academic Article
• Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins  Academic Article
• Another HIV vaccine failure: where to next?  Academic Article
• Anti-HIV B Cell lines as candidate vaccine biosensors  Academic Article
• Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection  Academic Article
• Anti-human immunodeficiency virus type 1 (hiv-1) antibodies 2f5 and 4e10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize hiv-1  Academic Article
• Antibodies against hiv-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy  Academic Article
• Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naive HIV-1-infected children from northern India  Academic Article
• Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike  Academic Article
• Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with cd4  Academic Article
• Antibody 2g12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the hiv-1 glycan shield if domain exchanged  Academic Article
• Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike  Academic Article
• Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG  Academic Article
• Antibody domain exchange is an immunological solution to carbohydrate cluster recognition  Academic Article
• Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics  Academic Article
• Antibody neutralization of HIV-1  Academic Article
• Antibody neutralization of hiv-1 and the potential for vaccine design  Academic Article
• Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1  Academic Article
• Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env  Academic Article
• Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design  Academic Article
• Antibody responses to envelope glycoproteins in HIV-1 infection  Academic Article
• Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization  Academic Article
• Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage  Academic Article
• Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins  Academic Article
• Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients: a follow-up study  Academic Article
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel  Academic Article
• Antiviral pressure exerted by hiv-1-specific cytotoxic t lymphocytes (ctls) during primary infection demonstrated by rapid selection of ctl escape virus  Academic Article
• Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry  Academic Article
• Are viral-encoded microRNAs mediating latent HIV-1 infection?  Academic Article
• Are viral-encoded microRNAs mediating latent HIV-1 infection?  Academic Article
• Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls  Academic Article
• Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California  Academic Article
• Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9  Academic Article
• Atomic-level modelling of the HIV capsid  Academic Article
• Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor  Academic Article
• B cell liaison confounds HIV-1 evolution  Academic Article
• B cell recognition of the conserved hiv-1 co-receptor binding site is altered by endogenous primate cd4  Academic Article
• B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models  Academic Article
• Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children  Academic Article
• Biochemically defined hiv-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the cd4-binding site  Academic Article
• Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection  Academic Article
• Block-And-Lock: New Horizons for a Cure for HIV-1  Academic Article
• Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals  Academic Article
• Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables  Academic Article
• Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface  Academic Article
• Broad and potent neutralization of hiv-1 by a gp41-specific human antibody  Academic Article
• Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target  Academic Article
• Broad distribution of energetically important contacts across an extended protein interface  Academic Article
• Broad hiv-1 neutralization mediated by cd4-binding site antibodies  Academic Article
• Broadly cross-reactive hiv-1-neutralizing human monoclonal fab selected for binding to gp120-cd4-ccr5 complexes  Academic Article
• Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers  Academic Article
• Broadly neutralizing anti-hiv-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface  Academic Article
• Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses  Academic Article
• Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41  Academic Article
• Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans  Academic Article
• Broadly neutralizing monoclonal antibodies 2f5 and 4e10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus shivba-l  Academic Article
• Building zinc fingers by selection - toward a therapeutic application  Academic Article
• CCL3L1 and HIV/AIDS susceptibility  Academic Article
• CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia  Academic Article
• CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120  Academic Article
• CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro  Academic Article
• CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity  Academic Article
• CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro  Academic Article
• CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor  Academic Article
• CD4-induced activation in a soluble HIV-1 Env trimer  Academic Article
• CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5  Academic Article
• CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies  Academic Article
• CRISPR-mediated activation of latent HIV-1 expression  Academic Article
• CXCR4 is down-regulated in cells infected with the CD4-independent X4 human immunodeficiency virus type 1 isolate m7NDK  Academic Article
• Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury  Academic Article
• Can gene delivery close the door to HIV-1 entry after escape?  Academic Article
• Catalytic contribution of flap-substrate hydrogen bonds in "HIV-1 protease" explored by chemical synthesis  Academic Article
• Cdr walking mutagenesis for the affinity maturation of a potent human anti-hiv-1 antibody into the picomolar range  Academic Article
• Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells  Academic Article
• Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity  Academic Article
• Cellular immunity elicited by human immunodeficiency virus type 1/simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies  Academic Article
• Challenges for structure-based HIV vaccine design  Academic Article
• Changes in HIV-1 tropism: clinical and prognostic consequences  Academic Article
• Changes in the V3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta 32 heterozygote  Academic Article
• Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity  Academic Article
• Characterization by serial deletion competition elisas of hiv-1 v3 loop epitopes recognized by monoclonal antibodies  Academic Article
• Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells  Academic Article
• Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants  Academic Article
• Characterization of antibody responses to purified hiv-1 gp120 glycoproteins fused with the molecular adjuvant c3d  Academic Article
• Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1  Academic Article
• Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization  Academic Article
• Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the cd4-bound state: Antigenicity, biophysics, and immunogenicity  Academic Article
• Characterization of primary isolate-like variants of simian-human immunodeficiency virus  Academic Article
• Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins  Academic Article
• Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants  Academic Article
• Chemical cross-linking stabilizes native-like HIV-1 envelope glycoprotein trimer antigens  Academic Article
• Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice  Academic Article
• Chemokine receptors in HIV-1 and SIV infection  Academic Article
• Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis  Academic Article
• Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation  Academic Article
• Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design  Academic Article
• Clinical applications of genome editing to HIV cure  Academic Article
• Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism  Academic Article
• Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding  Academic Article
• Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus  Academic Article
• Coevolution and subsite decomposition for the design of resistance-evading HIV-1 protease inhibitors  Academic Article
• Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease  Academic Article
• Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system  Academic Article
• Common genetic variation and the control of HIV-1 in humans  Academic Article
• Common immunological determinant between human-immunodeficiency-virus type-1 gp41 and astrocytes  Academic Article
• Comparative properties of feline immunodeficiency virus (fiv) and human immunodeficiency virus type 1 (hiv-1) proteinases prepared by total chemical synthesis  Academic Article
• Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque  Academic Article
• Comparing antigenicity and immunogenicity of engineered gp120  Academic Article
• Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer  Academic Article
• Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer  Academic Article
• Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies  Academic Article
• Comprehensive peptidomimetic libraries targeting protein-protein interactions  Academic Article
• Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data  Academic Article
• Conformation of the TAR RNA-arginine complex by NMR spectroscopy  Academic Article
• Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding  Academic Article
• Conformational changes of gp120 in epitopes near the ccr5 binding site are induced by cd4 and a cd4 miniprotein mimetic  Academic Article
• Conformational constraints imposed on a pan-neutralizing hiv-1 antibody epitope result in increased antigenicity but not neutralizing response  Academic Article
• Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions  Academic Article
• Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching  Academic Article
• Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion  Academic Article
• Copy Number Variation of KIR Genes Influences HIV-1 Control  Academic Article
• Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms  Academic Article
• Counteraction of HLA-C-mediated immune control of HIV-1 by Nef  Academic Article
• Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG  Academic Article
• Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals  Academic Article
• Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer  Academic Article
• Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome  Academic Article
• Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1  Academic Article
• Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262  Academic Article
• Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design  Academic Article
• Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3  Academic Article
• Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design  Academic Article
• Crystal structure of human antibody 2909 reveals conserved features of quaternary structure-specific antibodies that potently neutralize HIV-1  Academic Article
• Crystal structure of the broadly cross-reactive hiv-1-neutralizing fab x5 and fine mapping of its epitope  Academic Article
• Crystal structures of human immunodeficiency virus type 1 (hiv-1) neutralizing antibody 2219 in complex with three different v3 peptides reveal a new binding mode for hiv-1 cross-reactivity  Academic Article
• Crystal-structure of a human-immunodeficiency-virus type-1 neutralizing antibody, 50.1, in complex with its v3 loop peptide antigen  Academic Article
• Crystal-structure of the principal neutralization site of hiv-1  Academic Article
• Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: An antibody that broadly neutralizes primary isolates of HIV-1  Academic Article
• Crystallization, sequence, and preliminary crystallographic data for an antipeptide-fab-50.1 and peptide complexes with the principal neutralizing determinant of hiv-1 gp120  Academic Article
• Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease  Academic Article
• Cta1-dd adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization  Academic Article
• Custom-designed synthetic peptide immunoassays for distinguishing hiv type-1 and type-2 infections  Academic Article
• Cyclophilin A plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation  Academic Article
• Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L-cysteine  Academic Article
• DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication  Academic Article
• De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts  Academic Article
• Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease  Academic Article
• Defining HIV-1 protease substrate selectivity  Academic Article
• Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice  Academic Article
• Dense array of spikes on HIV-1 virion particles  Academic Article
• Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4  Academic Article
• Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse-transcriptase and suppress human and feline immunodeficiency virus expression in cultured-cells  Academic Article
• Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens  Academic Article
• Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly  Academic Article
• Detection of HIV-1 specific monoclonal antibodies using enhancement of dye-labeled antigenic peptides  Academic Article
• Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants  Academic Article
• Determinants flanking the cd4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 r5 envelopes  Academic Article
• Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble cd4 and monoclonal antibodies  Academic Article
• Determinants of polyreactivity in a large panel of recombinant human antibodies from hiv-1 infection  Academic Article
• Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy  Academic Article
• Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therap  Academic Article
• Development of cowpea mosaic-virus as a high-yielding system for the presentation of foreign peptides  Academic Article
• Development of functional human monoclonal single-chain variable fragment antibody against hiv-1 from human cervical b cells  Academic Article
• Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold  Academic Article
• Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies  Academic Article
• Didehydro-Cortistatin A: a new player in HIV-therapy?  Academic Article
• Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice  Academic Article
• Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits  Academic Article
• Differential expression profiles of apoptosis-affecting genes in hiv-infected cell lines and patient t cells  Academic Article
• Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level  Academic Article
• Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity  Academic Article
• Direct expression and validation of phage-selected peptide variants in mammalian cells  Academic Article
• Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance  Academic Article
• Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection  Academic Article
• Discovery and characterization of an endogenous CXCR4 antagonist  Academic Article
• Discovery of a distinct chemical and mechanistic class of allosteric HIV-1 integrase inhibitors with antiretroviral activity  Academic Article
• Disentangling human tolerance and resistance against HIV  Academic Article
• Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F  Academic Article
• Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors  Academic Article
• Dissection of the carbohydrate specificity of the broadly neutralizing-anti-hiv-1 antibody 2g12  Academic Article
• Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus  Academic Article
• Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus  Academic Article
• Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation  Academic Article
• Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization  Academic Article
• DoMCoSAR: A novel approach for establishing the docking mode that is consistent with the structure-activity relationship. Application to HIV-1 protease inhibitors and VEGF receptor tyrosine kinase inhibitors  Academic Article
• Dopamine receptor activation increases HIV entry into primary human macrophages  Academic Article
• Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies  Academic Article
• Dual specificity of a human neutralizing monoclonal antibody, specific for the v3 loop of gp120 (hiv-1)  Academic Article
• Dual-color HIV reporters trace a population of latently infected cells and enable their purification  Academic Article
• Dynamic models of viral replication and latency  Academic Article
• Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.  Academic Article
• Early modification of host cell gene expression induced by HIV-1  Academic Article
• Efavirenz intoxication due to a new CYP2B6 constellation  Academic Article
• Effect of Mg(2+) and Na(+) on the nucleic acid chaperone activity of HIV-1 nucleocapsid protein: implications for reverse transcription  Academic Article
• Effect of polyanion-resistance on HIV-1 infection  Academic Article
• Effective Pol III-expressed long hairpin RNAs targeted to multiple unique sites of HIV-1  Academic Article
• Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules  Academic Article
• Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice  Academic Article
• Efficient neutralization of primary isolates of hiv-1 by a recombinant human monoclonal-antibody  Academic Article
• Efficient recovery of high-affinity antibodies from a single-chain fab yeast display library  Academic Article
• Elicitation of simian immunodeficiency virus-specific cytotoxic t lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination  Academic Article
• Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types  Academic Article
• Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies  Academic Article
• Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy  Academic Article
• Enhanced exposure of the cd4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain  Academic Article
• Enhanced recognition and neutralization of HIV-1 by antibody-derived CCR5-mimetic peptide variants  Academic Article
• Enhancing t cell activation and antiviral protection by introducing the hiv-1 protein transduction domain into a DNA vaccine  Academic Article
• Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins  Academic Article
• Envelope diversity, characteristics of V3 region and predicted co-receptor usage of human immunodeficiency viruses infecting north Indians  Academic Article
• Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens  Academic Article
• Envelope glycoprotein internalization protects human and simian immunodeficiency virus-infected cells from antibody-dependent cell-mediated cytotoxicity  Academic Article
• Evaluation of HIV-1 inhibition by stereoisomers and analogues of the sesquiterpenoid hydroquinone peyssonol A  Academic Article
• Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide  Academic Article
• Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model  Academic Article
• Evaluation of protective immunity to HIV-1 in human PBL-SCID mice  Academic Article
• Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations  Academic Article
• Evolution of a TRIM5-CypA splice isoform in old world monkeys  Academic Article
• Evolutionary analysis of HIV-1 protease inhibitors: methods for design of inhibitors that evade resistance  Academic Article
• Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein  Academic Article
• Evolutionary genomics and HIV restriction factors  Academic Article
• Expanded breadth of virus neutralization after immunization with a multiclade envelope hiv vaccine candidate  Academic Article
• Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin  Academic Article
• Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C  Academic Article
• Factors limiting the immunogenicity of hiv-1 gp120 envelope glycoproteins  Academic Article
• Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system  Academic Article
• Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region  Academic Article
• Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing  Academic Article
• Formation of trans-activation competent hiv-1 rev:Rre complexes requires the recruitment of multiple protein activation domains  Academic Article
• Frequency and phenotype of human immunodeficiency virus envelope-specific b cells from patients with broadly cross-neutralizing antibodies  Academic Article
• Functional and immunological characterization of human-immunodeficiency-virus type-1 envelope glycoproteins containing deletions of the major variable regions  Academic Article
• Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion  Academic Article
• Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assembly  Academic Article
• Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody  Academic Article
• Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication  Academic Article
• Functional optimization of broadly neutralizing HIV-1 antibody 10E8 by promotion of membrane interactions  Academic Article
• Functional stability of HIV-1 envelope trimer affects accessibility to broadly neutralizing antibodies at its apex  Academic Article
• Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)  Academic Article
• Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody  Academic Article
• Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein e2c direct integration of viral DNA into specific sites  Academic Article
• Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats  Academic Article
• Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev  Academic Article
• Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization  Academic Article
• Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease  Academic Article
• Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule ccr5 inhibitor  Academic Article
• Genetic attributes of cerebrospinal fluid-derived HIV-1 env  Academic Article
• Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection  Academic Article
• Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy  Academic Article
• Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development  Academic Article
• Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals  Academic Article
• Genomic approaches to the study of HIV‐1 acquisition  Academic Article
• Genomics meets HIV-1  Academic Article
• Genomics of HIV infection  Academic Article
• Global landscape of HIV-human protein complexes  Academic Article
• Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies  Academic Article
• Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation  Academic Article
• Gp120: Biologic aspects of structural features  Academic Article
• Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity  Academic Article
• HIV displays its coat of arms  Academic Article
• HIV entry inhibitors  Academic Article
• HIV latency and the noncoding RNA therapeutic landscape  Academic Article
• HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase  Academic Article
• HIV-1 RNAs are not part of the argonaute 2 associated RNA interference pathway in macrophages  Academic Article
• HIV-1 Rev protein assembles on viral RNA one molecule at a time  Academic Article
• HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogene  Academic Article
• HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1  Academic Article
• HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists  Academic Article
• HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection  Academic Article
• HIV-1 elite controllers: Beware of super-infections  Academic Article
• HIV-1 entry and macrophage inflammatory protein-1 beta-mediated signaling are independent functions of the chemokine receptor CCR5  Academic Article
• HIV-1 envelope evolution and vaccine efficacy  Academic Article
• HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile  Academic Article
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites  Academic Article
• HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells  Academic Article
• HIV-1 infection and AIDS: consequences for the central nervous system  Academic Article
• HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis  Academic Article
• HIV-1 infection of nondividing cells - C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator  Academic Article
• HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway  Academic Article
• HIV-1 mRNA 3' end processing is distinctively regulated by elF3f, CDK11, and splice factor 9G8  Academic Article
• HIV-1 neutralizing antibodies induced by native-like envelope trimers  Academic Article
• HIV-1 neutralizing antibodies induced by native-like envelope trimers  Academic Article
• HIV-1 nucleocapsid protein switches the pathway of transactivation response element RNA/DNA annealing from loop-loop "kissing" to "zipper"  Academic Article
• HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization  Academic Article
• HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry  Academic Article
• HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists  Academic Article
• HIV-related neurotoxicity  Academic Article
• HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest  Academic Article
• HSV neutralization by the microbicidal candidate C5A  Academic Article
• Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells  Academic Article
• Herpesviruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract  Academic Article
• Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies  Academic Article
• Heterologous envelope immunogens contribute to aids vaccine protection in rhesus monkeys  Academic Article
• Heterologous epitope-scaffold prime:Boosting immuno-focuses b cell responses to the hiv-1 gp41 2f5 neutralization determinant  Academic Article
• Hexagonal assembly of a restricting trim5 alpha protein  Academic Article
• High-resolution definition of vaccine-elicited b cell responses against the hiv primary receptor binding site  Academic Article
• High-throughput protein engineering improves the antigenicity and stability of soluble HIV-1 envelope glycoprotein SOSIP trimers  Academic Article
• Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy  Academic Article
• Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression  Academic Article
• Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants  Academic Article
• Highly potent hiv-specific antibody neutralization in vitro translates into effective protection against mucosal shiv challenge in vivo  Academic Article
• Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin  Academic Article
• Hijacking and exploitation of il-10 by intracellular pathogens  Academic Article
• Hiv type 1 env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies  Academic Article
• Hiv-1 and influenza antibodies: Seeing antigens in new ways  Academic Article
• Hiv-1 env(gp140) trimers elicit neutralizing antibodies without efficient induction of conformational antibodies  Academic Article
• Hiv-1 neutralization: Mechanisms and relevance to vaccine design  Academic Article
• Hiv-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins  Academic Article
• Host and viral genetic correlates of clinical definitions of HIV-1 disease progression  Academic Article
• Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production  Academic Article
• Host cyclophilin A mediates HIV-1 attachment to target cells via heparans  Academic Article
• Host genes important to HIV replication and evolution  Academic Article
• Host genetics and HIV-1: the final phase?  Academic Article
• How HIV changes its tropism: evolution and adaptation?  Academic Article
• Human adipose cells express CD4, CXCR4, and CCR5 receptors: a new target cell type for the immunodeficiency virus-1  Academic Article
• Human antibody responses to hiv type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding  Academic Article
• Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses  Academic Article
• Human immunodeficiency virus infection of human-PBL-SCID mice  Academic Article
• Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases  Academic Article
• Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains  Academic Article
• Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations  Academic Article
• Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm  Academic Article
• Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein  Academic Article
• Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells  Academic Article
• Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein e2c can bias integration of viral DNA into a predetermined chromosomal region in human cells  Academic Article
• Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells  Academic Article
• Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody igg1b12  Academic Article
• Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons  Academic Article
• Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro  Academic Article
• Human monoclonal fab fragments specific for viral-antigens from combinatorial iga libraries  Academic Article
• Human monoclonal-antibodies against a plethora of viral pathogens from single combinatorial libraries  Academic Article
• Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes  Academic Article
• Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation  Academic Article
• Human xenograft models for virus infection  Academic Article
• Human-antibodies to hiv-1 by recombinant-DNA methods  Academic Article
• Human-immunodeficiency-virus infection of human brain capillary endothelial-cells occurs via a cd4 galactosylceramide-independent mechanism  Academic Article
• Hyperglycosylated mutants of human immunodeficiency virus (hiv) type 1 monomeric gp120 as novel antigens for hiv vaccine design  Academic Article
• Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies  Academic Article
• IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform  Academic Article
• IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV  Academic Article
• Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody  Academic Article
• Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12  Academic Article
• Identification of CD4-binding site dependent plasma neutralizing antibodies in an HIV-1 Infected Indian individual  Academic Article
• Identification of HIV-1 inhibitors targeting the nucleocapsid protein  Academic Article
• Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes  Academic Article
• Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design  Academic Article
• Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development  Academic Article
• Identification of peptides from human pathogens able to cross-activate an hiv-1-gag-specific cd4(+) t cell clone  Academic Article
• Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses  Academic Article
• Immune responses and HIV: A little order from the chaos  Academic Article
• Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice  Academic Article
• Immunization with recombinant hla classes i and ii, hiv-1 gp140, and siv p27 elicits protection against heterologous shiv infection in rhesus macaques  Academic Article
• Immunization with wild-type or cd4-binding-defective hiv-1 env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus  Academic Article
• Immunogenic display of purified chemically cross-linked HIV-1 spikes  Academic Article
• Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the v1/2 and v3 regions  Academic Article
• Immunogenicity of HIV-1 envelope glycoprotein oligomers  Academic Article
• Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines  Academic Article
• Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes  Academic Article
• Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection  Academic Article
• Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen  Academic Article
• Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+T cells  Academic Article
• Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element  Academic Article
• Improved breadth and potency of an hiv-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning  Academic Article
• Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers  Academic Article
• In vitro antigen challenge of human antibody libraries for vaccine evaluation: The human immunodeficiency virus type 1 envelope  Academic Article
• In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor  Academic Article
• In vitro whole-genome analysis identifies a susceptibility locus for HIV-1  Academic Article
• In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1  Academic Article
• In-vitro evolution of a neutralizing human-antibody to human-immunodeficiency-virus type-1 to enhance affinity and broaden strain cross-reactivity  Academic Article
• Incomplete neutralization and deviation from sigmoidal neutralization curves for HIV broadly neutralizing monoclonal antibodies  Academic Article
• Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate  Academic Article
• Increased functional stability and homogeneity of viral envelope spikes through directed evolution  Academic Article
• Increased hiv-1 vaccine efficacy against viruses with genetic signatures in env v2  Academic Article
• Independent genesis of chimeric TRIMS-cyclophilin proteins in two primate species  Academic Article
• Infection of intact human islets by a lentiviral vector  Academic Article
• Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes  Academic Article
• Influence of novel cd4 binding-defective hiv-1 envelope glycoprotein immunogens on neutralizing antibody and t-cell responses in nonhuman primates  Academic Article
• Influences on Trimerization and Aggregation of Soluble, Cleaved HIV-1 SOSIP Envelope Glycoprotein  Academic Article
• Influences on the design and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers  Academic Article
• Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappa B, and DNA by a designed DNA-binding ligand  Academic Article
• Inhibition of HIV-1 gene expression by a fragment of hnRNP U  Academic Article
• Inhibition of HIV-1 replication by elF3f  Academic Article
• Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol  Academic Article
• Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands  Academic Article
• Inhibition of hiv-1 entry by antibodies: Potential viral and cellular targets  Academic Article
• Inhibition of hiv-1 infectivity and epithelial cell transfer by human monoclonal igg and iga antibodies carrying the b12 v region  Academic Article
• Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent  Academic Article
• Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site  Academic Article
• Inhibition of virus attachment to cd4(+) target cells is a major mechanism of t cell line-adapted hiv-1 neutralization  Academic Article
• Innate immune defects in HIV permissive cell lines  Academic Article
• Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1  Academic Article
• Insights into the trimeric HIV-1 envelope glycoprotein structure  Academic Article
• Insights on the role of nucleic acid/protein interactions in chaperoned nucleic acid rearrangements of HIV-1 reverse transcription  Academic Article
• Integrin regulation of an inflammatory effector gene - direct induction of the tissue factor promoter by engagement of beta-1 or alpha-4 integrin chains  Academic Article
• Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of cxcl10/ip-10 gene expression by astrocytes in vivo and in vitro  Academic Article
• Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching  Academic Article
• Involvement of the v1/v2 variable loop structure in the exposure of human-immunodeficiency-virus type-1 gp120 epitopes induced by receptor-binding  Academic Article
• Is resistance futile?  Academic Article
• Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor  Academic Article
• LILRB2 interaction with HLA class I correlates with control of HIV-1 infection  Academic Article
• Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines  Academic Article
• Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection  Academic Article
• Lessons from the cat: Feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1  Academic Article
• Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category  Academic Article
• Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor  Academic Article
• Limited or no protection by weakly or nonneutralizing antibodies against vaginal shiv challenge of macaques compared with a strongly neutralizing antibody  Academic Article
• Lineage-specific viral hijacking of non-canonical E3 ubiquitin ligase cofactors in the evolution of Vif anti-APOBEC3 activity  Academic Article
• Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry  Academic Article
• Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells  Academic Article
• Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells  Academic Article
• Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient  Academic Article
• Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA  Academic Article
• Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller  Academic Article
• Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase a(2)  Academic Article
• Major antigen-induced domain rearrangements in an antibody  Academic Article
• Manipulating the selection forces during affinity maturation to generate cross-reactive hiv antibodies  Academic Article
• Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints  Academic Article
• Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy  Academic Article
• Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates  Academic Article
• Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries  Academic Article
• Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody  Academic Article
• Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody b12 that effectively targets the site of cd4 attachment  Academic Article
• Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01  Academic Article
• Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis  Academic Article
• Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS  Academic Article
• Mechanisms of neuronal injury and death in HIV-1 associated dementia  Academic Article
• Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein  Academic Article
• Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors  Academic Article
• Memantine for AIDS dementia complex: open-label report of ACTG 301  Academic Article
• Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains  Academic Article
• Mobilization-competent lentiviral vector-mediated sustained transcriptional modulation of HIV-1 expression  Academic Article
• Mode of action for linear peptide inhibitors of hiv-1 gp120 interactions  Academic Article
• Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy  Academic Article
• Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in escherichia coli  Academic Article
• Modeling AIDS in a mouse  Academic Article
• Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization  Academic Article
• Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution  Academic Article
• Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies  Academic Article
• Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells  Academic Article
• Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases  Academic Article
• Molecular characterization of the circulating anti-hiv-1 gp120-specific b cell repertoire using antibody phage display libraries generated from pre-selected hiv-1 gp120 binding pbls  Academic Article
• Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120  Academic Article
• Molecular mimicry accompanying HIV-1 infection - human monoclonal-antibodies that bind to gp41 and to astrocytes  Academic Article
• Molecular profile of an antibody-response to hiv-1 as probed by combinatorial libraries  Academic Article
• Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity  Academic Article
• Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys  Academic Article
• Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies  Academic Article
• Multiple antiviral activities of cyanovirin-n: Blocking of human immunodeficiency virus type 1 gp120 interaction with cd4 and coreceptor and inhibition of diverse enveloped viruses  Academic Article
• Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity  Academic Article
• Mutagenic stabilization and/or disruption of a cd4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein  Academic Article
• Mutations in the env gene of human immunodeficiency virus type 1 NDK isolates and the use of African green monkey CXCR4 as a co-receptor in COS-7 cells  Academic Article
• N-butyldeoxynojirimycin is a broadly effective anti-hiv therapy significantly enhanced by targeted liposome delivery  Academic Article
• N-linked glycosylation in the CXCR4 N-tenninus inhibits binding to HIV-1 envelope glycoproteins  Academic Article
• N332-directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function  Academic Article
• NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41  Academic Article
• Natural resistance of human immunodeficiency virus type 1 to the cd4bs antibody b12 conferred by a glycan and an arginine residue close to the cd4 binding loop  Academic Article
• Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells  Academic Article
• Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1  Academic Article
• Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists  Academic Article
• Neuronal injury associated with HIV-1: Approaches to treatment  Academic Article
• Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies  Academic Article
• Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity  Academic Article
• Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India  Academic Article
• Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of Anti-V3 antibody content and antiretroviral theraphy  Academic Article
• Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies  Academic Article
• Neutralization takes precedence over IgG or IgA isotype-related functions in mucosal HIV-1 antibody-mediated protection  Academic Article
• Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers  Academic Article
• Neutralizing activity of antibodies to the v3 loop region of hiv-1 gp120 relative to their epitope fine specificity  Academic Article
• Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins  Academic Article
• Neutralizing antibodies generated during natural hiv-1 infection: Good news for an hiv-1 vaccine?  Academic Article
• Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo  Academic Article
• Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation  Academic Article
• Neutralizing epitopes in the membrane-proximal external region of hiv-1 gp41 are influenced by the transmembrane domain and the plasma membrane  Academic Article
• Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to t cells  Academic Article
• Neutralizing recombinant human-antibodies to a conformational v2-binding and cd4-binding site-sensitive epitope of hiv-1 gp120 isolated by using an epitope-masking procedure  Academic Article
• New class of HIV-1 integrase (IN) inhibitors with a dual mode of action  Academic Article
• Nonhuman primate models and the failure of the merck hiv-1 vaccine in humans  Academic Article
• Nonneutralizing antibodies to the cd4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site  Academic Article
• Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus  Academic Article
• On resin side-chain cyclization of complex peptides using CuAAC  Academic Article
• Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C  Academic Article
• Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase  Academic Article
• Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04  Academic Article
• PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus  Academic Article
• PNA oligomers as tools for specific modulation of gene expression  Academic Article
• Passive immunization with a human monoclonal antibody protects hu-pbl-scid mice against challenge by primary isolates of hiv-1  Academic Article
• Pathogenesis of HIV-1 infection within bone marrow cells  Academic Article
• Pathways to neuronal injury and apoptosis in HIV-associated dementia  Academic Article
• Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the v3 loop of hiv-1  Academic Article
• Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals  Academic Article
• Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases  Academic Article
• Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 DNA candidate vaccine  Academic Article
• Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector  Academic Article
• Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load  Academic Article
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element  Academic Article
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1- (2,4-dimethyl-3-pyridinyl)carbonyl -4-methyl-4- 3(S)-methyl-4- 1(S)- 4-(trifluoro-methyl)phenyl ethyl -1-piperazinyl -piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist  Academic Article
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: Synthesis, antiviral and Pharmacokinetic profiles of symmetrical Heteroaryl Carboxamides  Academic Article
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1- (4,6-dimethyl-5-pyrimidinyl)carbonyl -4- 4-{2-methoxy-1(R)-4-(trifluo romethyl)-phenyl}ethyl-3(S)-methyl-1-piperazinyl -4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist  Academic Article
• Plasma membrane is the site of productive HIV-1 particle assembly  Academic Article
• Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines  Academic Article
• Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin  Academic Article
• Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection  Academic Article
• Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load  Academic Article
• Potent inhibition of hiv-1 entry with a chemically programmed antibody aided by an efficient organocatalytic synthesis  Academic Article
• Potent neutralization of primary human immunodeficiency virus clade c isolates with a synergistic combination of human monoclonal antibodies raised against clade b  Academic Article
• Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity  Academic Article
• Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5  Academic Article
• Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to hiv-1 gp120  Academic Article
• Primary infection by a human immunodeficiency virus with atypical coreceptor tropism  Academic Article
• Primary isolates of human-immunodeficiency-virus type-1 are relatively resistant to neutralization by monoclonal-antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120  Academic Article
• Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation  Academic Article
• Primate lentivirus capsid sensitivity to TRIM5 proteins  Academic Article
• Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate  Academic Article
• Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice  Academic Article
• Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen  Academic Article
• Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (hiv-1)  Academic Article
• Probing the structure of the human-immunodeficiency-virus surface glycoprotein gp120 with a panel of monoclonal-antibodies  Academic Article
• Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors  Academic Article
• Progress and prospects: RNA-based therapies for treatment of HIV infection  Academic Article
• Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV  Academic Article
• Promoter scanning for transcription inhibition with DNA-binding polyamides  Academic Article
• Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site  Academic Article
• Protective efficacy of broadly neutralizing antibodies with incomplete neutralization activity against simian-human immunodeficiency virus in rhesus monkeys  Academic Article
• Proteomic analysis of human immunodeficency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins  Academic Article
• Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization  Academic Article
• Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors  Academic Article
• Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates  Academic Article
• Rational HIV immunogen design to target specific germline B cell receptors  Academic Article
• Rational antibody-based HIV-1 vaccine design: current approaches and future directions  Academic Article
• Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1  Academic Article
• Reactivation of latent HIV-1 expression by engineered TALE transcription factors  Academic Article
• Reactivity-based one-pot synthesis of oligomannoses: Defining antigens recognized by 2g12, a broadly neutralizing anti-hiv-1 antibody  Academic Article
• Recognition properties of a panel of human recombinant fab fragments to the cd4 binding-site of gp120 that show differing abilities to neutralize human-immunodeficiency-virus type-1  Academic Article
• Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.  Academic Article
• Recombinant human fab fragments neutralize human type-1 immunodeficiency virus in vitro  Academic Article
• Recombinant human monoclonal antibody igg1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates  Academic Article
• Recombinant rabbit single-chain antibodies bind to the catalytic and c-terminal domains of hiv-1 integrase protein and strongly inhibit hiv-1 replication  Academic Article
• Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections  Academic Article
• Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop  Academic Article
• Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth  Academic Article
• Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions  Academic Article
• Reducing V3 antigenicity and immunogenicity on soluble, native-like HIV-1 Env SOSIP trimers  Academic Article
• Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease  Academic Article
• Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity  Academic Article
• Relationship between antibody 2f5 neutralization of hiv-1 and hydrophobicity of its heavy chain third complementarity-determining region  Academic Article
• Relationship of hiv-1 and siv envelope glycoprotein trimer occupation and neutralization  Academic Article
• Relationship of the human-immunodeficiency-virus type-1 gp120 3rd variable loop to a component of the cd4 binding-site in the 4th conserved region  Academic Article
• Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence  Academic Article
• Release of hydrogen-peroxide from human t-cell lines and normal lymphocytes co-infected with hiv-1 and mycoplasma  Academic Article
• Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design  Academic Article
• Replication and neutralization of human immunodeficiency virus type 1 lacking the v1 and v2 variable loops of the gp120 envelope glycoprotein  Academic Article
• Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates  Academic Article
• Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160  Academic Article
• Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use  Academic Article
• Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity  Academic Article
• Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs  Academic Article
• Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2  Academic Article
• Review of the twelfth west coast retrovirus meeting  Academic Article
• Rhesus macaque B-cell responses to an HIV-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis  Academic Article
• Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates  Academic Article
• Role of common human TRIM5α variants in HIV-1 disease progression  Academic Article
• Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization  Academic Article
• Role of seminal shedding of herpesviruses in HIV Type 1 transmission  Academic Article
• Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import  Academic Article
• SMYD2-mediated histone methylation contributes to HIV-1 latency  Academic Article
• Scorpion-toxin mimics of cd4 in complex with human immunodeficiency virus gp120: Crystal structures, molecular mimicry, and neutralization breadth  Academic Article
• Selection and evolution of high-affinity human anti-viral antibodies  Academic Article
• Selection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitors  Academic Article
• Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins  Academic Article
• Selection pressure on hiv-1 envelope by broadly neutralizing antibodies to the conserved cd4-binding site  Academic Article
• Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120  Academic Article
• Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope  Academic Article
• Selective recognition of oligomeric hiv-1 primary isolate envelope glycoprotelins by potently neutralizing ligands requires efficient precursor cleavage  Academic Article
• Semen-specific genetic characteristics of human immunodeficiency virus type 1 env  Academic Article
• Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells  Academic Article
• Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines  Academic Article
• Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides  Academic Article
• Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: Chemokine receptors, excitotoxicity, and beyond  Academic Article
• Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag  Academic Article
• Silencing of both β-TrCP1 and HOS (β-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation  Academic Article
• Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (hiv-1)-specific ipitopes: Replication, neutralization, and survey of hiv-1-positive plasma  Academic Article
• Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: Potential treatment with NMDA open-channel blockers and nitric oxide-related species  Academic Article
• Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography  Academic Article
• Single-cell analysis identifies cellular markers of the HIV permissive cell  Academic Article
• Single-cell and deep sequencing of IgG-switched macaque B cells reveal a diverse Ig repertoire following immunization  Academic Article
• Single-molecule studies reveal that dead box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element  Academic Article
• Single-particle image reconstruction of a tetramer of hiv integrase bound to DNA  Academic Article
• Small animal models for acquired immune deficiency syndrome (AIDS) research  Academic Article
• Small molecule regulation of protein conformation by binding in the flap of HIV protease  Academic Article
• Small-molecule cd4 mimics interact with a highly conserved pocket on hiv-1 gp120  Academic Article
• Small-molecule inhibitors: viral fusion arrested  Academic Article
• Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins  Academic Article
• Soluble hiv-1 env trimers in adjuvant elicit potent and diverse functional b cell responses in primates  Academic Article
• Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: Characterization and ligand binding analysis  Academic Article
• Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120  Academic Article
• Somatic cell genetic analyses to identify HIV-1 host restriction factors  Academic Article
• Specific interaction of feline immunodeficiency virus surface glycoprotein with human dc-sign  Academic Article
• Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice  Academic Article
• Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein  Academic Article
• Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain  Academic Article
• Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies  Academic Article
• Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies  Academic Article
• Stimulation of enveloped virus infection by beta-amyloid fibrils  Academic Article
• Stimulation of the primary anti-hiv antibody response by ifn-alpha in patients with acute hiv-1 infection  Academic Article
• Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers  Academic Article
• Structural and functional evaluation ofde novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens  Academic Article
• Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins  Academic Article
• Structural and mechanistic bases for a potent HIV-1 capsid inhibitor  Academic Article
• Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01  Academic Article
• Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases  Academic Article
• Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10  Academic Article
• Structural basis of immune evasion at the site of cd4 attachment on hiv-1 gp120  Academic Article
• Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120  Academic Article
• Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers  Academic Article
• Structural constraints determine the glycosylation of HIV-1 envelope trimers  Academic Article
• Structural definition of a conserved neutralization epitope on HIV-1 gp120  Academic Article
• Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers  Academic Article
• Structural dynamics of hiv-1 rev and its complexes with rre and 5s rna  Academic Article
• Structural evolution of glycan recognition by a family of potent HIV antibodies  Academic Article
• Structural insights into key sites of vulnerability on hiv-1 env and influenza ha  Academic Article
• Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3  Academic Article
• Structural interactions between chemokine receptors, gp120 Env and CD4  Academic Article
• Structural rationale for the broad neutralization of hiv-1 by human monoclonal antibody 447-52d  Academic Article
• Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors  Academic Article
• Structural studies of FIV and HIV-1 proteases complexed with all efficient inhibitor of FIV protease  Academic Article
• Structural studies of human HIV-1 V3 antibodies  Academic Article
• Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1  Academic Article
• Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence  Academic Article
• Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2f5 in complex with its gp41 epitope  Academic Article
• Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9  Academic Article
• Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies  Academic Article
• Structure of a v3-containing hiv-1 gp120 core  Academic Article
• Structure of antibody f425-b4e8 in complex with a v3 peptide reveals a new binding mode for hiv-1 neutralization  Academic Article
• Structure of full-length hiv-1ca: A model for the mature capsid lattice  Academic Article
• Structure of hiv-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility  Academic Article
• Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex  Academic Article
• Structure-activity relationships in the binding of chemically derivatized cd4 to gp120 from human immunodeficiency virus  Academic Article
• Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site  Academic Article
• Structure-based design of a protein immunogen that displays an hiv-1 gp41 neutralizing epitope  Academic Article
• Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase  Academic Article
• Structure-based vaccine design in hiv: Blind men and the elephant?  Academic Article
• Structure-based, targeted deglycosylation of hiv-1 gp120 and effects on neutralization sensitivity and antibody recognition  Academic Article
• Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody  Academic Article
• Structure-guided alterations of the gp41-directed hiv-1 broadly neutralizing antibody 2f5 reveal new properties regarding its neutralizing function  Academic Article
• Structure-guided redesign increases the propensity of HIV Env to generate highly stable soluble trimers  Academic Article
• Structures of hiv-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates  Academic Article
• Structures of the ccr5 n terminus and of a tyrosine-sulfated antibody with hiv-1 gp120 and cd4  Academic Article
• Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays  Academic Article
• Successful efavirenz dose reduction guided by therapeutic drug monitoring  Academic Article
• Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays  Academic Article
• Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid  Academic Article
• Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices  Academic Article
• Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1  Academic Article
• Syndecan-fc hybrid molecule as a potent in vitro microbicidal anti-hiv-1 agent  Academic Article
• Syndecans and HIV-1 pathogenesis  Academic Article
• Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages  Academic Article
• Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins  Academic Article
• Synthesis and biological evaluation of 2 ',4 '- and 3 ',4 '-bridged nucleoside analogues  Academic Article
• Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA  Academic Article
• Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies  Academic Article
• T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery  Academic Article
• T-cell recognition of hiv synthetic peptides in a natural infection  Academic Article
• TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human langerhans cells ex vivo  Academic Article
• Targeted killing of yeast expressing a hiv-1 peptide by antibody-conjugated glucose-oxidase and horseradish-peroxidase  Academic Article
• Targeting HIV transcription: the quest for a functional cure  Chapter
• Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules  Academic Article
• Targeting sites within HIV-1 cDNA with a DNA-cleaving ribozyme  Academic Article
• Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN  Academic Article
• The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function  Academic Article
• The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells  Academic Article
• The Tat inhibitor didehydro-Cortistatin A prevents HIV-1 reactivation from latency  Academic Article
• The Tat inhibitor didehydro-cortistatin a prevents HIV-1 reactivation from latency  Academic Article
• The antibody response in HIV-1 infection  Academic Article
• The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets  Academic Article
• The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates  Academic Article
• The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry  Academic Article
• The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2g12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120  Academic Article
• The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12  Academic Article
• The ccr5 receptor acts as an alloantigen in ccr5 delta 32 homozygous individuals: Identification of chemokine- and hiv-1-blocking human antibodies  Academic Article
• The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes  Academic Article
• The challenges of eliciting neutralizing antibodies to hiv-1 and to influenza virus  Academic Article
• The chemistry of site-directed serology for HIV infections  Academic Article
• The contribution of various NOS gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury  Academic Article
• The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus  Academic Article
• The development of cowpea mosaic virus as a potential source of novel vaccines  Academic Article
• The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies  Academic Article
• The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA  Academic Article
• The emerging role of long non-coding RNAs in HIV infection  Academic Article
• The envelope glycoprotein ectodomains determine the efficiency of cd4(+) t lymphocyte depletion in simian-human immunodeficiency virus-infected macaques  Academic Article
• The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes  Academic Article
• The evolution of catalytic function in the HIV-1 protease  Academic Article
• The fusion peptide domain is the primary membrane-inserted region and enhances membrane interaction of the ectodomain of HIV-1 gp41  Academic Article
• The genomic signature of population reconnection following Isolation: from theory to HIV  Academic Article
• The glycan shield of hiv is predominantly oligomannose independently of production system or viral clade  Academic Article
• The hiv-1 envelope glycoproteins: Fusogens, antigens, and immunogens  Academic Article
• The hiv-1 nef protein inhibits extracellular signal-regulated kinase-dependent DNA synthesis in a human astrocytic cell line  Academic Article
• The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions  Academic Article
• The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice 
• The inhibitory efficacy of RNA POL III-Expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat  Academic Article
• The integrase interactor I (INII) proteins facilitate Tat-mediated human immunodeficiency virus type I transcription  Academic Article
• The interplay between host genetic variation, viral replication, and microbial translocation in untreated HIV-infected individuals  Academic Article
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry  Academic Article
• The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries  Academic Article
• The membrane-proximal external region of hiv-1 gp41: A vaccine target worth exploring  Academic Article
• The nef gene from a long-term hiv type 1 nonprogressor  Academic Article
• The nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix  Academic Article
• The neuropathogenesis of HIV-1 infection  Academic Article
• The neutralizing antibody response to hiv-1: Viral evasion and escape from humoral immunity  Academic Article
• The novel cyclophilin inhibitor CPI-431-32 concurrently blocks HCV and HIV-1 infections via a similar mechanism of action  Academic Article
• The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1  Academic Article
• The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry  Academic Article
• The role of tripartite motif family members in mediating susceptibility to HIV-1 infection  Academic Article
• The saga of MHC-bound peptides: a renaissance for antigen presentation?  Academic Article
• The structural biology of HIV assembly  Academic Article
• The therapeutic application of CRISPR/Cas9 technologies for HIV  Academic Article
• Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys  Academic Article
• Total syntheses of thiocoraline and be-22179 and assessment of their DNA binding and biological properties  Academic Article
• Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding  Academic Article
• Trans-complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity  Academic Article
• Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells  Academic Article
• Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers  Academic Article
• Transplanting supersites of HIV-1 vulnerability  Academic Article
• Trim5α accelerates degradation of cytosolic capsid associated with productive HIV-1 entry  Academic Article
• Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures  Academic Article
• Tumor necrosis factor in the pathogenesis of infectious diseases  Academic Article
• Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES  Academic Article
• Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120  Academic Article
• Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry  Academic Article
• Tyrosine-sulfate isosteres of ccr5 n-terminus as tools for studying hiv-1 entry  Academic Article
• Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region  Academic Article
• Up-regulation of human immunodeficiency virus-1 in chronically infected monocytic cell-line by both contact with endothelial-cells and cytokines  Academic Article
• Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency viruses  Academic Article
• Using HIV Networks to Inform Real Time Prevention Interventions  Academic Article
• Using HIV sequence and epidemiologic data to assess the effect of self-referral testing for acute HIV infection on incident diagnoses in San Diego, California  Academic Article
• V1/V2 neutralizing epitope is conserved in divergent non-M groups of HIV-1  Academic Article
• VRX-496(VIRxSYS)  Academic Article
• Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates  Academic Article
• Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign  Academic Article
• Vaccine-elicited tier 2 HIV-1 neutralizing antibodies bind to quaternary epitopes involving glycan-deficient patches proximal to the CD4 binding site  Academic Article
• Variable loop glycan dependency of the broad and potent hiv-1-neutralizing antibodies pg9 and pg16  Academic Article
• Variation in hiv-i r5 macrophage-tropism correlates with sensitivity to reagents that block envelope: Cd4 interactions but not with sensitivity to other entry inhibitors  Academic Article
• Very few substitutions in a germ line antibody are required to initiate significant domain exchange  Academic Article
• Virucidal effect of myeloperoxidase on human-immunodeficiency-virus type 1-infected t-cells  Academic Article
• Virucidal effects of glucose-oxidase and peroxidase or their protein conjugates on human-immunodeficiency-virus type-1  Academic Article
• Virus and target cell evolution in human immunodeficiency virus type 1 infection  Academic Article
• Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype  Academic Article
• Virus-specific cd8+ cytotoxic t-lymphocyte activity associated with control of viremia in primary human-immunodeficiency-virus type-1 infection  Academic Article
• Visualization of the HIV-1 Env glycan shield across scales  Academic Article
• Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties  Academic Article
• Whither or wither microbicides?  Academic Article
• X-ray structures of the hexameric building block of the HIV capsid  Academic Article
• ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression  Academic Article
• Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration  Academic Article
• Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment  Academic Article
• [HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia] [Article in Spanish]  Academic Article
• eCD4-Ig variants that more potently neutralize HIV-1  Academic Article
• gp120 and neurotoxicity in vivo  Academic Article
• gp41: HIV's shy protein  Academic Article